TABLE 12.
TREATED EYES (n=233) (222 EYES TESTED) | CONTROL EYES (n=230) (222 EYES TESTED) | COMBINED EYES (n=463) (444 EYES TESTED) | ELBW COHORT (n=48) | |
---|---|---|---|---|
Favorable | 104 (46.8%) | 77 (34.7%) | 181 (40.8%) | 43 (89.6%) |
20/40 or better | 28 (12.6%) | 37 (16.7%) | 65 (14.6%) | 25 (52.1%) |
<20/40, but 20/60 or better | 14 (6.3%) | 11 ( 5.0%) | 25 ( 5.6%) | 8 (16.7%) |
<20/60, but >20/200 | 62 (27.9%) | 29 (13.1%) | 91 (20.5%) | 10 (20.8%) |
Unfavorable | 118 (53.1%) | 145 (65.3%) | 263 (59.2%) | 5 (10.4%) |
≤20/200 | 48 (21.6%) | 39 (17.6%) | 87 (19.6%) | 1 ( 2.1%) |
Blind | 70 (31.5%) | 106 (47.7%) | 176 (39.6%) | 4 ( 8.3%) |
CRYO-ROP = Cryotherapy for Retinopathy of Prematurity